ATE409191T1 - 1,3-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung - Google Patents

1,3-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung

Info

Publication number: ATE409191T1
Authority: AT; Austria
Prior art keywords: production; dibenzoazulene; diaza; inhibitors; necrosis factor
Prior art date: 2002-05-23

Application number

AT03755236T

Other languages

English (en)

Inventor

Mladen Mercep

Milan Mesic

Renata Rupcic

Dijana Pesic

Original Assignee

Glaxosmithkline Zagreb

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-23

Filing date

2003-05-20

Publication date

2008-10-15

2003-05-20 Application filed by Glaxosmithkline Zagreb filed Critical Glaxosmithkline Zagreb

2008-10-15 Application granted granted Critical

2008-10-15 Publication of ATE409191T1 publication Critical patent/ATE409191T1/de

Links

NKTGZAKMRRHEKM-UHFFFAOYSA-N 3,5-diazatetracyclo[12.4.0.02,6.08,13]octadeca-1(18),2,4,6,8,10,12,14,16-nonaene Chemical compound N1=CN=C2C3=C(C4=C(C=C12)C=CC=C4)C=CC=C3 NKTGZAKMRRHEKM-UHFFFAOYSA-N 0.000 title 1
108060008682 Tumor Necrosis Factor Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
239000013067 intermediate product Substances 0.000 title 1
102000003390 tumor necrosis factor Human genes 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AT03755236T 2002-05-23 2003-05-20 1,3-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung ATE409191T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HR20020453A HRP20020453A2 (en)	2002-05-23	2002-05-23	1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof

Publications (1)

Publication Number	Publication Date
ATE409191T1 true ATE409191T1 (de)	2008-10-15

Family

ID=29559974

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03755236T ATE409191T1 (de)	2002-05-23	2003-05-20	1,3-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung

Country Status (15)

Country	Link
US (1)	US7166583B2 (de)
EP (1)	EP1509528B1 (de)
JP (1)	JP2005531586A (de)
CN (1)	CN100354277C (de)
AR (1)	AR040040A1 (de)
AT (1)	ATE409191T1 (de)
AU (1)	AU2003232372A1 (de)
CA (1)	CA2487017A1 (de)
DE (1)	DE60323748D1 (de)
ES (1)	ES2314237T3 (de)
HR (1)	HRP20020453A2 (de)
IS (1)	IS7568A (de)
PL (1)	PL374504A1 (de)
RS (1)	RS100104A (de)
WO (1)	WO2003099823A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE362534T2 (de)	1998-11-13	2007-06-15	Immunex Corp	Menschliche tslp nukleinsäuren und polypeptide
PT1417231E (pt)	2001-07-23	2013-07-29	Immunex Corp	Linfopoietina estromal tímica humana modificada
HRP20020304B1 (en) *	2002-04-10	2008-04-30	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20030958A2 (en) *	2003-11-21	2005-08-31	Pliva-Istra�iva�ki institut d.o.o.	USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
EP1793856A2 (de) *	2004-08-20	2007-06-13	Amgen Inc.	Verfahren und zusammensetzungen zur behandlung allergischer entzündungen
US20080096830A1 (en) *	2005-01-13	2008-04-24	Mladen Mercep	Anti-Inflammatory Macrolide Conjugates
EP1989187A4 (de) *	2006-02-24	2009-07-08	Merck Frosst Canada Ltd	2-(phenyl- oder -heterocyclyl)-1h-phenanthro(9,10-d)imidazole
US7982016B2 (en)	2007-09-10	2011-07-19	Amgen Inc.	Antigen binding proteins capable of binding thymic stromal lymphopoietin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3711489A (en) *	1971-03-31	1973-01-16	Pfizer	Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
FR2211218A1 (en) *	1972-12-21	1974-07-19	Pfizer	Dibenzocyclooctaimidazoles - useful as anti inflammatories
US4215135A (en) *	1979-06-08	1980-07-29	E. I. Du Pont De Nemours And Company	Antiinflammatory 2-substituted-1H-phenanthro[9,10-d]imidazoles
US4198421A (en) *	1978-11-30	1980-04-15	E. I. Du Pont De Nemours And Company	Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
US4305954A (en) *	1981-02-11	1981-12-15	E. I. Du Pont De Nemours And Company	Antiinflammatory 3,4-dihydro(or 1,4-dihydro)-2-[(substituted)thio]-[1]benzopyrano[3,4-d]imidazoles and their corresponding sulfoxides and sulfones
CA2003283A1 (en)	1988-12-05	1990-06-05	C. Anne Higley	Imidazoles for the treatment of atherosclerosis
US5166214A (en)	1988-12-05	1992-11-24	Du Pont Merck Pharmaceutical Company	Use of imidazoles for the treatment of atherosclerosis
IL132318A0 (en)	1997-04-24	2001-03-19	Ortho Mcneil Pharm Inc	Substituted imidazoles useful in the treatment of inflammatory diseases
HRP20000310A2 (en)	2000-05-17	2002-02-28	Pliva Farmaceutska Ind Dioniko	New dibenzoazulene compounds as tumor necrosis factor inhibitors

2002
- 2002-05-23 HR HR20020453A patent/HRP20020453A2/hr not_active Application Discontinuation
2003
- 2003-05-20 PL PL03374504A patent/PL374504A1/xx not_active Application Discontinuation
- 2003-05-20 JP JP2004507480A patent/JP2005531586A/ja active Pending
- 2003-05-20 CA CA002487017A patent/CA2487017A1/en not_active Abandoned
- 2003-05-20 US US10/515,711 patent/US7166583B2/en not_active Expired - Fee Related
- 2003-05-20 EP EP03755236A patent/EP1509528B1/de not_active Expired - Lifetime
- 2003-05-20 WO PCT/HR2003/000025 patent/WO2003099823A2/en not_active Ceased
- 2003-05-20 CN CNB038161214A patent/CN100354277C/zh not_active Expired - Fee Related
- 2003-05-20 DE DE60323748T patent/DE60323748D1/de not_active Expired - Fee Related
- 2003-05-20 ES ES03755236T patent/ES2314237T3/es not_active Expired - Lifetime
- 2003-05-20 AT AT03755236T patent/ATE409191T1/de not_active IP Right Cessation
- 2003-05-20 AU AU2003232372A patent/AU2003232372A1/en not_active Abandoned
- 2003-05-20 RS YU100104A patent/RS100104A/sr unknown
- 2003-05-23 AR ARP030101804A patent/AR040040A1/es not_active Application Discontinuation
2004
- 2004-11-29 IS IS7568A patent/IS7568A/is unknown

Also Published As

Publication number	Publication date
ES2314237T3 (es)	2009-03-16
HRP20020453A2 (en)	2003-12-31
CN100354277C (zh)	2007-12-12
IS7568A (is)	2004-11-29
WO2003099823A2 (en)	2003-12-04
DE60323748D1 (de)	2008-11-06
CA2487017A1 (en)	2003-12-04
EP1509528A2 (de)	2005-03-02
CN1665513A (zh)	2005-09-07
EP1509528B1 (de)	2008-09-24
PL374504A1 (en)	2005-10-31
AR040040A1 (es)	2005-03-09
US20050227963A1 (en)	2005-10-13
AU2003232372A1 (en)	2003-12-12
WO2003099823A3 (en)	2004-04-29
JP2005531586A (ja)	2005-10-20
RS100104A (sr)	2006-10-27
US7166583B2 (en)	2007-01-23

Legal Events

Date	Code	Title	Description
2009-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE442348T1 (de)	2009-09-15	Amino substituierte phenylessigsäuren sowie deren derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren
ATE415966T1 (de)	2008-12-15	Substituierte 3-amino-thieno(2,3-b)pyridine-2- amide und herstellungsverfahren sowie deren verwendung
DE60324228D1 (de)	2008-12-04	Harte Überzugzusammensetzung und damit beschichtete Gegenstände
DE602005027546D1 (de)	2011-06-01	Aryl- und heteroarylpiperidincarboxylatderivate, deren herstellung und deren verwendung in form von faah-enzyminhibitoren
PL372926A1 (en)	2005-08-08	Piperidine-pyridazones and phthalazones as pde4 inhibitors
ATE491701T1 (de)	2011-01-15	Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung
ATE524178T1 (de)	2011-09-15	Acylierte, heteroaryl-kondensierte cycloalkenylamine und deren verwendung als arzneimittel
ATE438630T1 (de)	2009-08-15	5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
ATE325789T1 (de)	2006-06-15	Aminocyclohexylether-verbindungen und deren verwendung
EP1469860A4 (de)	2005-09-07	Antikrebskombination und deren verwendung
MX2007002470A (es)	2009-02-12	Fenilaminotiazoles sustituidos y su uso.
DE50208918D1 (de)	2007-01-18	6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
DE60009155D1 (de)	2004-04-22	Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung
DE60313895D1 (de)	2007-06-28	2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren
DE60218807D1 (de)	2007-04-26	Rutheniumkomplexe und deren Verwendung zur Herstellung von Alkoholen
ATE369371T1 (de)	2007-08-15	1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
DE60334632D1 (de)	2010-12-02	Mechanolumineszenzstoff und dessen herstellung
PL1608811T3 (pl)	2008-04-30	Wyrób wielowarstwowy i sposób jego wytwarzania
DE60206289D1 (de)	2006-02-02	Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
ATE409191T1 (de)	2008-10-15	1,3-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
ITMI20022704A1 (it)	2004-06-21	Procedimento per la produzione di mesitilene e durene.
ATE343582T1 (de)	2006-11-15	Derivate von (6, 7-dihydro -5h-imidazo(1,2 - a)imidazol -3 -sulfonylamino)-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen
ATE398621T1 (de)	2008-07-15	1,2-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung
DE50313185D1 (de)	2010-11-25	2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva
ATE404545T1 (de)	2008-08-15	Acylaminothiazolderivate, verfahren zu deren herstellung und deren verwendung als inhibitoren der produktion von beta-amyloidpeptid